References
- Verma RK, Garg S. Current status of drug delivery technologies and future directions. Pharm Tech 2001;25(2): 1–14.
- Speers M, Bonnano C. Economic aspects of controlled drug delivery. In Mathiowitz: Encyclopedia of controlled drug delivery. New York: Wiley; 1999:34 1–347.
- Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Cont Rel. 2002;79:7–27.
- Shargel L, Yu ABC. Pharmacokinetic and pharmacodynamic parameters for selected drugs. In: Applied biopharmaceutics and pharmacokinetics. 3rd ed. New York: Prentice-Hall; 1993:594.
- Santus G, Baker WR. Osmotic drug delivery: A review of patent literature. J Cont Rel 1995;35:1–21.
- Wakode R, Bahanushali R, Bajaj A. Development and evaluation of push pull based osmotic delivery system for pramipexol. J Pharm Sci Technol 2008;62(1):22–31.
- Geerke JH. Method and apparatus for forming dispenser delivery ports. United States patent number 5,658,474.
- Sean CS. Martindale: The complete drug reference. 34th ed. London: Pharmaceutical Press; 2005:301–301.
- Baldessarini R, Tarazi F. Drugs and the treatment of psychiatric disorders. In Hardman JG, editor. Goodman and Gilman’s pharmacological basis of therapeutics. 10th ed. USA: McGraw-Hill; 2001:485–520.
- Amdisen A. Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokin 1977;2:73–92.
- Schou M. Serum lithium monitoring of prophylactic treatment: Critical review and updated recommendations. Clin Pharma 1988;15:283–286.
- Hunter R. Steady-state pharmacokinetics of lithium carboante in healthy subjects. Br J Clin Pharmac 1988;25:375–380.
- Thase M. Selecting appropriate treatments for maintenance therapy for bipolar disorder. J Clin Psychiatry 2008;69/5:28–35.
- Young AH, J Newham JI. Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol 2006;2:17–22.
- Bowden C. The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse. Curr Psychiatry Rep 2000;6:490–494.
- Langer R. Drug delivery and targeting. Nature 1998;392:5–10.
- Swanson DR, Barclay BL, Wong PS, Theeuwes F. Nifedipine gastrointestinal therapeutic system. Am J Med 1987;83:3–10.
- Late SG, Yu Y, Banga AK. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets. Int J Pharm 2009;365:4–11.
- Stober HC. Lithium carbonate. In: Florey K, editor. Analytical profiles of drug substances. New York: Academic Press; 2005;15:367–391.
- Zentner G, Rork G, Himmelstein K. Osmotic flow through controlled porosity films: An approach to delivery of water soluble compounds. J Cont Rel 1985;2:217–229.
- Rajan K, Kaushal A, Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int J Pharm 2003;263:9–24.
- Schultz PA, Kleinebudde P. A new multiparticulate delayed release system Part I: Dissolution properties and release mechanism. J Cont Rel 1997;47:181–189.
- Higuchi T. Mechanism of sustained action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–1149.
- Costa P, Lobo J. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133.
- Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol 1996;20:64–74.